Trending Now
Tivic Health Systems Inc. (NASDAQ: TIVC): A Promising Leap with New...
Tivic Health® Systems, Inc. (NASDAQ: TIVC), a pioneering health tech company in bioelectronic medicine, recently announced significant advancements with the grant of...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Hepion Pharmaceuticals Inc (NASDAQ:HEPA) Completes The Study Of CRV431
The enrolment of several subjects in the Hepion Pharmaceuticals Inc (NASDAQ:HEPA) Phase 1b multiple ascending dose ("MAD") study focusing on CRV431 was a step...
MAKE IT MODERN
LATEST REVIEWS
Altamira Therapeutics Ltd. (NASDAQ: CYTO) Announce Encouraging Bentrio Results in Influenza...
Altamira Therapeutics Ltd. (NASDAQ: CYTO) has announced positive results from Bentrio (AM-301) testing for therapeutics or prophylactic use in Influenza A virus treatment. Bentrio...
MAKE IT MODERN
PERFORMANCE TRAINING
The FDA Agrees With Aldeyra Therapeutics Inc. (NASDAQ:ALDX) On RASP Inhibitor In Dry Eye...
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) has announced that it has reached an agreement with the FDA regarding the uses of reactive aldehyde species (RASP) as...
Aravive Inc (NASDAQ: ARAV) Reports Improved Tolerability In Patients With Advanced Stage Kidney Cancer...
Aravive Inc (NASDAQ: ARAV) posted an initial readout of the positive results from the phase 1b clinical study of AVB-500 in combination therapy with...
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) Enters Co-Promotion Partnership Deal For Probuphine Implant With Indegene
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has announced that it has signed a co-promotion partnership agreement with Indegene Inc. The partnership is meant to establish multichannel...
Alexion (NASDAQ:ALXN) Receives FDA Approval For ULTOMIRIS® 100 mg/mL Formulation In Treating PNH and...
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) has received approval from the US FDA for ULTOMIRIS® (ravlizumab-cwvz) 100mg/mL formulation.
ULTOMIRIS® can reduce the time spent to receive treatment...
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) Will Support a New Drug Application (NDA) for Dry Eye...
Dry eyes come with discomfort and pain. It can be irritating, and statistics show that more than 15 million detected cases of dry eye...
MAKE IT MODERN
